Atria Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$560K Sell
5,787
-599
-9% -$61.4K 0.01% 1388
2025
Q4
$678K Sell
6,386
-259
-4% -$30K 0.01% 1278
2025
Q3
$844K Sell
6,645
-455
-6% -$54.2K 0.01% 1140
2025
Q2
$871K Sell
7,100
-905
-11% -$103K 0.01% 1115
2025
Q1
$811K Sell
8,005
-1,004
-11% -$98K 0.01% 1096
2024
Q4
$832K Sell
9,009
-82
-0.9% -$8.05K 0.01% 1077
2024
Q3
$879K Sell
9,091
-2,740
-23% -$246K 0.01% 1037
2024
Q2
$1.02M Buy
+11,831
New +$993K 0.01% 918
2024
Q1
Sell
-17,857
Closed -$1.19M 973
2023
Q4
$1.19M Sell
17,857
-1,885
-10% -$122K 0.02% 817
2023
Q3
$1.33M Buy
+19,742
New +$1.36M 0.02% 728
2020
Q2
Sell
-4,777
Closed -$243K 594
2020
Q1
$243K Buy
+4,777
New +$275K 0.02% 480

Other funds holding EHC

Atria Investments's EHC Position: Q1 2026 in Review

Atria Investments reduced its Encompass Health (EHC) stake by 9.4% in Q1 2026, selling an estimated $61.4K and leaving 5,787 shares worth $560K. The position accounts for 0.01% of the portfolio, ranked #1388.

Atria Investments first reported a position in EHC in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.33M in Q3 2023. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Atria Investments held 5,787 shares of Encompass Health worth $560K as of Q1 2026.
  • Atria Investments sold 599 Encompass Health shares in Q1 2026, an estimated $61.4K.
  • Encompass Health made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1388 holding.
  • Atria Investments first reported a position in Encompass Health in Q1 2020 and has held it in 11 quarters since.
  • Atria Investments's Encompass Health position peaked at $1.33M in Q3 2023.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.